# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Joe Louis (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX002-SYN
- Date: 2026-07-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Desmond Achterberg-Cole, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

One-week review of persecutory thoughts, seen the same day by addiction psychiatry. **S**

## History of present illness

Mr. Louis returns one week after intake and is seen by Dr. Featherstone-Ibe of addiction psychiatry on the same day. He has used no cocaine since three days before his intake visit, ten days in all, and has kept his naloxone and test strips at home. The belief that people are following him and plan to harm him is less intense but still there; he checks the street from his window several times a night and sleeps about four hours. He has had no hallucinations and no thoughts of harming himself or anyone else, and he has not confronted anyone. The phone check three days after intake found him safe. The intake urine test, done with his consent, was positive for cocaine and negative for fentanyl, other opioids, amphetamines, benzodiazepines and cannabis. HIV, hepatitis C and syphilis tests were negative; he is not infected with hepatitis B and is not immune. His thyroid and vitamin B12 tests were normal. His brain MRI this morning showed no contusion, microbleeds or other abnormality. He wants to get well and agreed to the specialist plan. **S**

| Element | Detail |
|---|---|
| Last cocaine use | Ten days ago |
| Persecutory beliefs | Present, less intense; partial insight |
| Sleep | About four hours |
| Intake results | Urine positive for cocaine, negative for fentanyl and other drugs; HIV, hepatitis C and syphilis negative; hepatitis B not immune; TSH and B12 normal |
| Brain MRI | Normal for age |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired from short sleep; appetite normal |
| Cardiovascular | Negative | No chest pain or palpitations since the collapse |
| Neurological | Negative | No headache, weakness or numbness |
| Psychiatric | Positive | Persecutory beliefs persist; no hallucinations; no thoughts of suicide or of harming anyone |

4 systems reviewed. **S**

## Current medications

- Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives with **S**
- Aripiprazole 5 mg oral tablet, one tablet each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 148/94 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 98% on room air; weight 101 kg; BMI 28.9 kg/m². All vital signs are synthetic.

Total cholesterol: 204 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol (calculated): 128 mg/dL (high); Triglycerides: 160 mg/dL (high). All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Alert; blood pressure 148/94, pulse 90; weight 101.0 kg |
| Ears, nose, mouth, and throat | Nasal septum intact |
| Neurological | Cranial nerves normal; no tremor, rigidity or abnormal movements (AIMS 0); gait normal |
| Psychiatric | Courteous and watchful; persecutory delusion held less firmly than a week ago; no hallucinations; oriented; no suicidal or homicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Cocaine use disorder, severe, with cocaine-induced psychotic disorder** (F14.250). Dr. Featherstone-Ibe confirms a severe cocaine use disorder with a cocaine-induced psychotic disorder: the delusions began during heavy use, he has never had psychotic symptoms off cocaine, they are already fading, and the examination, laboratory tests and MRI show no other cause. A primary psychotic disorder would be considered again if symptoms outlast a month of abstinence. Because they persist ten days after his last use and keep him from sleeping, an antipsychotic is advised. Safety reviewed: no thoughts of suicide or of harming anyone; the safety plan is in his phone. **S**
   - Aripiprazole 5 mg each morning, with a plan to taper after a period of remission.
   - Contingency management with twice-weekly urine tests and prize draws for twelve weeks, starting today.
   - Weekly cognitive behavioral therapy with the clinic counselor.
   - Baseline fasting lipids today; hemoglobin A1c 5.5% and QTc 436 ms at intake.
2. **Raised blood pressure** (R03.0). 148/94 mmHg ten days after cocaine; still raised. **S**
   - Home blood pressure readings twice daily in the week before the four-week visit.
3. **Financial insecurity** (Z59.86). Money worries keep him awake. **S**
   - Meeting with the clinic social worker next week.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Cocaine use since the last visit (his own account), cravings and triggers | Every visit | Completed today | No cocaine for ten days; cravings in the evenings |
| Laboratory | Urine drug tests in contingency management, with fentanyl, and prize draws for negative results | Twice weekly for twelve weeks, then at visits | Completed today | Intake test positive for cocaine, negative for fentanyl; contingency management begins today with the first test, negative |
| Examination | Psychotic symptoms, insight and sleep | Every visit | Completed today | Persecutory beliefs less firmly held; no hallucinations; sleep about four hours |
| Medication safety | Antipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS) | Weight and akathisia at every visit while on treatment; AIMS at baseline and every six months | Completed today | Baseline before aripiprazole: weight 101.0 kg, BMI 28.9, blood pressure 148/94; AIMS 0; no akathisia; QTc 436 ms at intake |
| Laboratory | Fasting glucose or hemoglobin A1c and lipids on an antipsychotic | Baseline, at four months, then yearly | Completed today | Baseline fasting lipids today: total cholesterol 204, HDL 44, LDL 128, triglycerides 160 mg/dL; hemoglobin A1c 5.5% at intake |
| Examination | Cognitive screen (MoCA) | At baseline and again once he is well and off cocaine | Up to date | MoCA 25 at intake during symptoms and short sleep; repeat once he is well |
| Imaging | Brain MRI for new psychotic symptoms after age 50 | Once, at presentation | Completed today | No contusion, microbleeds or mass; brain volume normal for age |
| Examination | Blood pressure in clinic and at home | Every visit; home readings before diagnosis and after each change | Ordered | 148/94 mmHg; home readings planned before the four-week visit |
| Survey | Suicide and violence risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or of harming anyone; no firearms; 988 saved in his phone |
| Medication safety | Naloxone and fentanyl test strips on hand | Every visit | Completed today | Naloxone and test strips at home; he knows how to use them |
| Survey | Depression (PHQ-9) and anxiety (GAD-7) | At baseline and every four weeks while in treatment | Up to date | PHQ-9 8 and GAD-7 9 at intake; repeat at four weeks |
| Self-management | Cognitive behavioral therapy | Weekly | Ordered | First session booked this week |
| Self-management | Finances, social work and taxpayer services | Every visit | Ordered | Social work appointment next week |
| Self-management | Family involvement, only with his consent | Every visit | Completed today | He does not want family contacted for now; respected |
| Referral | Addiction psychiatry consultation | At the start of treatment | Completed today | Seen by Dr. Featherstone-Ibe today |

## Goal progress

- Persecutory fears gone and six or more hours of sleep. In progress; target 2026-08-10. **S**
- No cocaine use, his goal, with contingency management and cognitive behavioral therapy. In progress; target 2026-10-26. **S**
- Blood pressure below 130/80 mmHg. In progress; target 2026-10-26. **S**
- A clear answer about his memory and thinking once he is well. In progress; target 2026-09-21. **S**
- A plan for money that lets him sleep. In progress; target 2026-10-26. **S**

## Medication changes

- Started: Aripiprazole 5 mg oral tablet, one tablet each morning **S**

## Guideline basis

- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023), American Society of Addiction Medicine and American Academy of Addiction Psychiatry (Journal of Addiction Medicine 2024;18(1S Suppl 1):1-56)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020), American Psychiatric Association (American Journal of Psychiatry 2020;177(9):868-872)
- Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021), Substance Abuse and Mental Health Services Administration
- National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021), Neurology 2021;96(18):848-863
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026), Aether Forge

## Follow-up

- Four-week review in three weeks with home blood pressure readings, the PHQ-9 and GAD-7. Contingency management twice weekly and therapy weekly. Call the clinic or 988, or go to the emergency department, for any of the urgent signs on his plan. **S**
- Next scheduled visit 2026-08-10: four-week review: psychotic symptoms, urine tests, blood pressure and a diagnosis of hypertension. **S**
